Related Experiment Video
Updated: Feb 5, 2026

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest
Published on: January 5, 2018
Effectiveness of antiarrhythmic drugs for shockable cardiac arrest: A systematic review
Muhammad Usman Ali1, Donna Fitzpatrick-Lewis2, Meghan Kenny1
1McMaster Evidence Review and Synthesis Centre, McMaster University, 1280 Main St. W., McMaster Innovation Park, Room 207A, Hamilton, Ontario, L8S 4K1, Canada; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Room HSC-2C, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada.
Insights
Antiarrhythmic drugs show no benefit for survival in shockable cardiac arrest. Lidocaine may improve return of spontaneous circulation, but more research is needed for critical outcomes.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Cardiac arrest management guidelines emphasize timely interventions.
- Antiarrhythmic drugs are frequently used in advanced cardiac life support protocols.
- Evidence on their effectiveness in shockable cardiac arrest requires regular updates.
Purpose of the Study:
- To systematically review current evidence on antiarrhythmic drug efficacy in shockable cardiac arrest.
- To inform the 2018 International Liaison Committee on Resuscitation Consensus on Science with Treatment Recommendations.
- To evaluate outcomes such as survival and neurological function.
Main Methods:
- Comprehensive search of Medline, Embase, and Cochrane Library databases.
- Inclusion of randomized controlled trials (RCTs) and observational studies up to August 2017.
- Analysis of adult and pediatric populations separately.
Main Results:
- RCTs in adults found no significant difference for antiarrhythmic drugs versus placebo for survival to discharge or good neurological function.
- Lidocaine showed a statistically significant increase in return of spontaneous circulation compared to placebo (RR=1.16; 95% CI, 1.03-1.29).
- Limited evidence exists for pediatric populations and specific post-resuscitation scenarios.
Conclusions:
- High-level evidence for antiarrhythmic drug benefit in shockable cardiac arrest is limited.
- No demonstrated benefit for critical outcomes like survival or neurological function.
- Further research is essential to clarify the role of these drugs, especially in pediatric cases and post-ROSC adults.
Purpose:
The purpose of this systematic review is to provide up-to-date evidence on effectiveness of antiarrhythmic drugs for shockable cardiac arrest to help inform the 2018 International Liaison Committee on Resuscitation Consensus on Science with Treatment Recommendations.
Methods:
A search was conducted in electronic databases Medline, Embase, and Cochrane Library from inception to August 15, 2017.
Results:
Of the 9371 citations reviewed, a total of 14 RCTs and 17 observational studies met our inclusion criteria for adult population and only 1 observational study for pediatric population. Based on RCT level evidence for adult population, none of the anti-arrhythmic drugs showed any difference in effect compared with placebo, or with other anti-arrhythmic drugs for the critical outcomes of survival to hospital discharge and discharge with good neurological function. For the outcome of return of spontaneous circulation, the results showed a significant increase for lidocaine compared with placebo (RR = 1.16; 95% CI, 1.03-1.29, p = 0.01).
Conclusion:
The high level evidence supporting the use of antiarrhythmic drugs during CPR for shockable cardiac arrest is limited and showed no benefit for critical outcomes of survival at hospital discharge, survival with favorable neurological function and long-term survival. Future high quality research is needed to confirm these findings and also to evaluate the role of administering antiarrhythmic drugs in children with shockable cardiac arrest, and in adults immediately after ROSC.
More Related Videos
10:55A Piglet Perinatal Asphyxia Model to Study Cardiac Injury and Hemodynamics after Cardiac Arrest, Resuscitation, and the Return of Spontaneous Circulation
Published on: January 13, 2023
10:25Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
Published on: August 30, 2011
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview